CANO HEALTH INC (CANO) Stock Analyst Ratings
USA - New York Stock Exchange - NYSE:CANO - US13781Y2028 - Common Stock
2.3 USD
-0.05 (-2.13%)
1.17 USD
-1.13 (-49.13%)
ChartMill assigns a Buy % Consensus number of 49% to CANO. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 4.85. This target is 110.65% above the current price.
CANO was analyzed by 9 analysts. The buy percentage consensus is at 49. So analysts seem to be rather neutral about CANO.
In the previous month the buy percentage consensus was at a similar level.
CANO was analyzed by 9 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2023-11-17 | UBS | Downgrade | Neutral -> Sell |
| 2023-08-14 | Credit Suisse | Maintains | Neutral -> Neutral |
| 2023-08-11 | Citigroup | Downgrade | Buy -> Neutral |
| 2023-08-11 | Jefferies | Downgrade | Buy -> Hold |
| 2023-05-16 | Piper Sandler | Maintains | Underweight -> Underweight |
| 2023-05-12 | Credit Suisse | Reiterate | Neutral -> Neutral |
| 2023-01-06 | UBS | Downgrade | Buy -> Neutral |
| 2023-01-05 | Wolfe Research | Downgrade | Outperform -> Peer Perform |
| 2022-12-13 | B of A Securities | Reiterate | Underperform |
| 2022-11-16 | Citigroup | Maintains | Buy |
| 2022-11-10 | Cowen & Co. | Downgrade | Outperform -> Market Perform |
| 2022-11-10 | Raymond James | Downgrade | Outperform -> Market Perform |
| 2022-10-27 | Credit Suisse | Downgrade | Outperform -> Neutral |
| 2022-09-07 | Truist Securities | Initiate | Hold |
| 2022-06-24 | Raymond James | Initiate | Outperform |
| 2022-06-15 | B of A Securities | Downgrade | Buy -> Neutral |
| 2022-05-11 | Credit Suisse | Maintains | Outperform |
| 2022-05-11 | Piper Sandler | Maintains | Underweight |
| 2022-05-10 | Citigroup | Maintains | Buy |
| 2022-05-03 | B of A Securities | Initiate | Buy |
| 2022-04-20 | UBS | Initiate | Buy |
| 2021-10-20 | Jefferies | Initiate | Buy |
| 2021-10-19 | Piper Sandler | Initiate | Neutral |
| 2021-10-01 | Wolfe Research | Initiate | Outperform |
| 2021-09-21 | Citigroup | Initiate | Buy |
| 2021-09-10 | Cowen & Co. | Initiate | Outperform |
| 2021-08-02 | Credit Suisse | Initiate | Outperform |
CANO HEALTH INC / CANO FAQ
What do analysts expect the price target to be for CANO HEALTH INC (CANO)?
9 analysts have analysed CANO and the average price target is 4.85 USD. This implies a price increase of 110.65% is expected in the next year compared to the current price of 2.3.
What is the consensus rating for CANO stock?
The consensus rating for CANO HEALTH INC (CANO) is 48.8889 / 100 . This indicates that analysts generally have a neutral outlook on the stock.